Muscular dystrophy biotech aTyr Pharma sets terms for $75 million IPO

Muscular dystrophy biotech aTyr Pharma sets terms for $75 million IPO

4/27/15

Related Post

aTyr Pharma Announces Encouraging Phase 1b/2 Resul...
views 176
Thu, Mar 31, 2016, 2:09AM EDT - US Markets open in 7 hrs and 21 mins  aTyr Pharma Announces Encouraging Phase 1b/2 Results for Resolaris™ in its First...
ATyr Pharma Raises $76M Round to Advance Physocrin...
views 200
ARS 전문 바이오벤쳐기업 ATyr Pharma가 7천 6백만 달러 (약 800억원)의 투자유치에 성공했다는 소식입니다. 첨부한 PDF 파일을 참조하시기 바랍니다. ...
2015.10.08 Osong BioExcellence & BioTech Fair
views 220
지난 10월 8일 충북 오송에서 열린   2015 Osong BioExcellence & BioTech Fair에서 Dr. Thomas Neenan 이 Creating Value from an Academic Pipeline 이란 주제로 바이오콘 pipeline...
0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2018 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar